AU5282200A - Methods of reducing factor viii clearance and compositions therefor - Google Patents

Methods of reducing factor viii clearance and compositions therefor

Info

Publication number
AU5282200A
AU5282200A AU52822/00A AU5282200A AU5282200A AU 5282200 A AU5282200 A AU 5282200A AU 52822/00 A AU52822/00 A AU 52822/00A AU 5282200 A AU5282200 A AU 5282200A AU 5282200 A AU5282200 A AU 5282200A
Authority
AU
Australia
Prior art keywords
methods
factor viii
compositions therefor
reducing factor
viii clearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52822/00A
Other languages
English (en)
Inventor
Evgueni L. Saenko
Dudley K. Strickland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American National Red Cross
Original Assignee
American National Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American National Red Cross filed Critical American National Red Cross
Publication of AU5282200A publication Critical patent/AU5282200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU52822/00A 1999-05-24 2000-05-24 Methods of reducing factor viii clearance and compositions therefor Abandoned AU5282200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13584799P 1999-05-24 1999-05-24
US60135847 1999-05-24
PCT/US2000/014111 WO2000071714A2 (fr) 1999-05-24 2000-05-24 Procedes de reduction de la clairance du facteur viii et compositions correspondantes

Publications (1)

Publication Number Publication Date
AU5282200A true AU5282200A (en) 2000-12-12

Family

ID=22469983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52822/00A Abandoned AU5282200A (en) 1999-05-24 2000-05-24 Methods of reducing factor viii clearance and compositions therefor

Country Status (3)

Country Link
EP (1) EP1183354A2 (fr)
AU (1) AU5282200A (fr)
WO (1) WO2000071714A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794493B2 (en) 2000-04-07 2004-09-21 Wisys Technology Foundation, Inc. Antithrombin H-helix mutants
CA2434097A1 (fr) * 2001-01-12 2002-08-08 The American National Red Cross Methodes et compositions permettant de reduire la clairance du facteur viii, mediee par l'heparan-sulfate proteoglycane
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP1454916A1 (fr) * 2002-11-29 2004-09-08 ZLB Behring GmbH ADNc modifié du facteur VIII et dérivés
EP1424344A1 (fr) * 2002-11-29 2004-06-02 Aventis Behring Gesellschaft mit beschränkter Haftung ADNc modifié du facteur VIII et dérivés
EP1444986A1 (fr) * 2003-02-07 2004-08-11 Aventis Behring GmbH Preparation pharmaceutique pour l'amélioration du traitement des maladies liées à une coagulation sanguine diminuée
EP1454632A1 (fr) * 2003-02-07 2004-09-08 Aventis Behring GmbH, Intellectual Property/Legal Composé pharmaceutique contenant des peptides dérivés du facteur VIII pour le traitement de troubles de la coagulation sanguine
US20050026823A1 (en) * 2003-06-20 2005-02-03 Biomarin Pharmaceutical Inc. Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
EP1502921A1 (fr) * 2003-07-29 2005-02-02 ZLB Behring GmbH Mutants du Facteur VIII (FVIII) humain recombinants ayant une meilleure stabilité
US7211559B2 (en) 2003-10-31 2007-05-01 University Of Maryland, Baltimore Factor VIII compositions and methods
CN101124331B (zh) 2004-11-12 2013-04-24 拜尔健康护理有限责任公司 Fvⅲ的位点定向修饰
JP2008534559A (ja) * 2005-04-01 2008-08-28 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 血液凝固ｆｖｉｉｉ類似体
JP2008537680A (ja) * 2005-04-14 2008-09-25 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 安定性の増大された改変型凝固第ｖｉｉｉ因子およびその誘導体
US8877714B2 (en) * 2005-06-14 2014-11-04 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereof
WO2007035716A2 (fr) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations
EP1816201A1 (fr) 2006-02-06 2007-08-08 CSL Behring GmbH Facteur de coagulation VIIa modifié ayant une stabilité 'half-life' améliorée
AU2007338298B2 (en) 2006-12-22 2013-02-07 Csl Behring Gmbh Modified coagulation factors with prolonged in vivo half-life
EP1935430A1 (fr) * 2006-12-22 2008-06-25 CSL Behring GmbH Facteurs de coagulation modifiés avec une demi-vie in vivo prolongée
EP3114138B1 (fr) 2014-03-05 2021-11-17 Pfizer Inc. Mutéines améliorées du facteur viii de coagulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859204A (en) 1992-04-07 1999-01-12 Emory University Modified factor VIII
WO1995018827A1 (fr) * 1994-01-07 1995-07-13 Novo Nordisk A/S Derives du facteur viii
US5650391A (en) * 1994-03-21 1997-07-22 Jewish Hospital Of St. Louis Methods and compositions for inhibition of hepatic clearance of tissue factor pathway inhibitor
AU6486196A (en) 1995-07-11 1997-02-10 Chiron Corporation Novel factor viii:c polypeptide analogs with altered protease sites
AT403438B (de) * 1996-05-24 1998-02-25 Immuno Ag Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität
PT1129186E (pt) * 1998-11-10 2007-12-07 Sanquin Bloedvoorziening Um polipéptido factor viii com actividade de factor viii-c
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen

Also Published As

Publication number Publication date
WO2000071714A3 (fr) 2001-01-18
EP1183354A2 (fr) 2002-03-06
WO2000071714A2 (fr) 2000-11-30

Similar Documents

Publication Publication Date Title
AU5282200A (en) Methods of reducing factor viii clearance and compositions therefor
AUPQ419099A0 (en) Novel compositions and methods
AU2609901A (en) Antimicrobial compositions and methods of use
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU5230399A (en) Pharmaceutical compositions and methods for managing scalp conditions
AU5699799A (en) Makeup compositions and methods of making same
AU4133701A (en) Methods and compositions for peptide synthesis
PL335168A1 (en) Compositions for and methods of reducing intracocular hypertension
AU3887900A (en) Protamine fragment compositions and methods of use
AU3495199A (en) Abrasive silica compositions and dentifrice compositions prepared therefrom
AU2349399A (en) R-lansoprazole compositions and methods
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU5800399A (en) Polish composition and method of use
AU7358800A (en) Compositions and methods for modification of skin lipid content
AU7651100A (en) Pharmaceutical and/or cosmetical compositions
AU4834200A (en) Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
AU2674399A (en) Compositions and methods for the inhibition of muc-5 mucin gene expression
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
EP1163340A4 (fr) Compositions et methodes de modification de l'expression genique
AU3902799A (en) Compositions and methods for genetic transformation of pineapple
AU2221400A (en) Compositions containing and methods of using n-acyl-1h-aminoindenes
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU1477601A (en) Genetic compositions and methods
AU1943501A (en) Methods of treating inflammation and compositions therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase